Advertisement Bristol-Myers selects LabCorp Clinical Trials for global central laboratory services - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Bristol-Myers selects LabCorp Clinical Trials for global central laboratory services

Bristol-Myers Squibb Company has selected Laboratory Corporation of America Holdings (LabCorp) Clinical Trials for global central laboratory services and biomarker testing services for a period of five years.

LabCorp chief medical officer Dr. Mark Brecher said, "We are excited to expand our relationship with Bristol-Myers Squibb to provide a more flexible and integrated approach to laboratory testing services in support of their innovative clinical development pipeline."

Earlier, Bristol-Myers’ early and late-stage clinical development programs were supported by LabCorp’s global central lab, biomarker and specialty testing capabilities.